Jaguar Gene’s JAG201 therapy trial for autism receives FDA approval

Jaguar Gene Therapy has received clearance from the FDA for JAG201, a gene replacement therapy, in a Phase I clinical trial for autism.

Comments

  • No comments yet.
  • Add a comment